Researchers spun PRP from 11 volunteers using the Arthrex ACP Double Syringe System and the Biomet GPS III Mini Platelet Concentration System. The Arthrex system concentrates platelets and minimizes leukocytes while the Biomet system concentrates both platelets and leukocytes.
The growth factors were significantly increased with the Biomet system, compared with the Arthrex system, and the Arthrex system did not have a concentration of PDGF-AB when compared with whole blood. The cellular composition of the PRP had an impact on the growth factor and catabolic cytkine concentrations.
Study authors Brian J. Cole, MD, MBA, and Lisa A. Fortier, DVM, PhD, wrote a letter to the editor clarifying this article, and you can view the letter here.
Related Articles on PRP:
7 Things Orthopedic Surgeons Should Know About Platelet-Rich Plasma
Is PRP a Passing Trend or the Future of Sports Medicine?: 4 Physician Responses
PRP Use for Orthopedics: Updates and Standards From AAOS
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
